Cytokines profile in pure neural leprosy

Front Immunol. 2023 Dec 5:14:1272471. doi: 10.3389/fimmu.2023.1272471. eCollection 2023.

Abstract

Introduction: Pure Neural Leprosy (PNL) is a form of this long time known disease that affects only the peripheral nervous system. Since it is a rare form of the disease, its pathophisiology is still poorly understood.

Objective: Describe the cytokines profile in patients with PNL.

Methods: 30 Patients diagnosed with PNL in the Souza Araujo Outpatient Clinic and with cytokines evaluated were selected. They were evaluated by neurologists and diagnosed after a nerve biopsy. Serum levels of IL-1 β, IL-6, IL-10, IL-17, TNF, CCL-2/MCP-1, IFN-ϒ, CXCL-10/IP-10 and TGF-β were evaluates at the moment of the diagnosis.

Results: Neural thickening was a common clinical finding in this groups of patients. Small and medium sensitive fibers signs and symptoms were present in 92% of the patients and motor involvement in 53%. 43% of patients presented neuropathic pain and no one had neuritis TGF-beta, IL-17, CCl-2 and IP-10. CCL-2 levels were associated with demyelinating patters and IP-10 and IL-1o were associated with axonal patterns at NCS.

Discussion: PNL patients' cytokine profile appears to be different of other clinical forms of leprosy, with the presence of cytokines described in both tuberculoid and lepromatous leprosy. High levels of CCl-2 may be related to the presence of silent neuritis as well as the presence of IL-10. PNL is unique a form of leprosy, therefore, understanding its immunological profiles essential to better understand the disease itself.

Keywords: cytokine profile; leprosy nerve conduction studies; leprosy neuropathy; leprosy reactions; pure neural leprosy.

Publication types

  • Comment

MeSH terms

  • Chemokine CXCL10
  • Cytokines
  • Humans
  • Interleukin-10
  • Interleukin-17
  • Leprosy*
  • Leprosy, Tuberculoid* / diagnosis
  • Leprosy, Tuberculoid* / pathology
  • Neuritis*
  • Transforming Growth Factor beta

Substances

  • Cytokines
  • Interleukin-10
  • Interleukin-17
  • Chemokine CXCL10
  • Transforming Growth Factor beta

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.